ArticleHepatobiliary surgery and nutrition2026
Robotic versus laparoscopic liver resection for the treatment of hepatocellular carcinoma: an observational study.
Article in Hepatobiliary surgery and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Compared to laparoscopic liver resection (LLR), robotic liver resection (RLR) can offer patients better outcomes but higher costs. And currently, real-world observational evidence from China regarding this topic remains understudied. This study aimed to compare the cost difference between RLR and LLR and its association with surgical difficulty, thereby providing new insights for surgical decision-making. Methods: We retrospectively collected data from patients with hepatocellular carcinoma (HCC) who underwent liver resection by a single medical team at one hospital in China, from January 2016 to July 2023. Patients were divided into the RLR group and the LLR group. We compared perioperative outcomes and medical costs before and after propensity score matching (PSM), then conducted subgroup analyses with surgical difficulty as a covariate. Results: A total of 277 patients were included (175 in LLR group and 102 in RLR group). After PSM, 162 patients (81 in each group) were included for further analysis. The results showed that RLR group had less intraoperative bleeding, fewer postoperative complications, shorter postoperative hospital stay, and better surgical safety compared to LLR group. RLR group had higher medical costs (¥82,885.3 Conclusions: For patients with HCC, RLR had better surgical safety and higher medical costs compared to LLR. However, the non-surgical costs of RLR were lower. Furthermore, the increase in surgical difficulty reduced the cost difference between the two surgical methods, recommending RLR for patients with high surgical difficulty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.